# Diabetic Retinopathy Candesartan Trials

> **NCT00252733** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5238 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** candesartan cilexetil

## Key facts

- **NCT ID:** NCT00252733
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 5238 (ACTUAL)
- **Last updated:** 2014-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252733, "Diabetic Retinopathy Candesartan Trials". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00252733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*